Making Sense of Incretin Science Understanding the difference between GLP-1 and GIP helps demystify why certain weight loss medications work better than others
10.1172/jci.insight.133429 18 GBD 2015 Obesity CollaboratorsAfshinA.ForouzanfarM
Enhanced eryptosis following exposure to lopinavir
Additionally, proteolytic degradation is a major challenge in peptide-based therapeutics, as it results in short half-life, low bioavailability, rapid clearance, and ultimately reduced therapeutic efficacy
These include: Reduced activity in nerve cells responsible for coordinating movement Lower levels of growth hormones, testosterone and insulin-like growth factor A reduced ability to convert protein into energy Elevated inflammation Anabolic resistance, the age-related suppression of muscle protein synthesis after a dose of protein/amino acids 4 In addition to aging, muscle atrophy can also be caused by disuse, such as when patients are sedentary for long periods